Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11788059 Modified NK-92 cells for treating cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
July 27, 2020
Date of Patent
October 17, 2023
Patent Applicant
ImmunityBio
ImmunityBio
Patent Application Number
16940018
Patent Citations
‌
US Patent 8034332 Interleukin-secreting natural killer cell lines and methods of use
‌
US Patent 8313943 Genetically modified human natural killer cell lines
‌
US Patent 8906682 Methods for treatment of cancer
‌
US Patent 8946385 Chimeric Fcγ receptor and method for determination of ADCC activity by using the receptor
‌
US Patent 10738279 Modified NK-92 cells for treating cancer
‌
US Patent 10765701 Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells
‌
US Patent 7098008 Selected primers for detection of MAGE or GAGE genes for diagnosis of cancer and methods of use
‌
US Patent 7351801 Method, use and kit for separating albumin from contaminants in a liquid
‌
US Patent 7351803 CD16A binding proteins and use for the treatment of immune disorders
‌
US Patent 7618817 Genetically modified human natural killer cell lines
Patent Inventor Names
Tien Lee
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11788059
Patent Primary Examiner
‌
Brad Duffy

Find more entities like US Patent 11788059 Modified NK-92 cells for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo